4.5 Article

Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK/JNK/ASK signaling pathway in rats

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation

Satoyasu Ito et al.

Summary: The study suggests that Juzentaihoto (TJ-48) may exert a renal protective effect in mice with adenine-induced chronic kidney disease by suppressing fibrosis and inflammation.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)

Article Pharmacology & Pharmacy

Effects of long-term infliximab and tocilizumab treatment on anxiety-like behavior and cognitive function in naive rats

Frideriki Poutoglidou et al.

Summary: This study demonstrates that long-term treatment with anti-TNF-α and IL-6 inhibitors can improve anxiety and cognitive function in rats, leading to increased BDNF expression in the brain.

PHARMACOLOGICAL REPORTS (2022)

Article Urology & Nephrology

Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats

Raphaelle Corremans et al.

Summary: This study evaluated the therapeutic efficacy of metformin and canagliflozin in slowing the progression of non-diabetic CKD. Metformin showed protective effects against kidney impairment, while canagliflozin did not. Proteomic analysis revealed that metformin's kidney-protective effect was associated with the activation of the Hippo signaling pathway.

KIDNEY INTERNATIONAL (2022)

Article Medicine, Research & Experimental

Infliximab and/or MESNA alleviate doxorubicin-induced Alzheimer's disease-like pathology in rats: A new insight into TNF-α/Wnt/β-catenin signaling pathway

Hoda E. Mohamad et al.

Summary: The current study aimed to investigate the neurotoxic potential of DOX in inducing AD-like pathology and the efficacy of infliximab (IFX) and 2-mercaptoethane sulfonate sodium (MESNA) in attenuating DOX-induced neurotoxicity. The results showed that both IFX and MESNA significantly mitigated DOX-induced brain injury, neuroinflammation, and apoptosis, with the best improvement observed with their combined administration.

LIFE SCIENCES (2022)

Article

Protective effects of lycopene against adenine-induced chronic renal failure in rats

Pooja Gori et al.

Indian Journal of Physiology and Pharmacology (2021)

Article Pharmacology & Pharmacy

Inactivation of Wnt/β-catenin/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats

Nahla N. Younis et al.

Summary: IFX has a positive effect on DOX-induced nephropathy by up-regulating renal klotho to inhibit the Wnt/β-catenin pathway, reducing inflammation and fibrosis.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats

Aly M. Abdelrahman et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)

Article Integrative & Complementary Medicine

Anemoside B4 Protects Rat Kidney from Adenine-Induced Injury by Attenuating Inflammation and Fibrosis and Enhancing Podocin and Nephrin Expression

Qin Gong et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)

Article Medicine, Research & Experimental

The effect of sildenafil on rats with adenine-Induced chronic kidney disease

Badreldin H. Ali et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Urology & Nephrology

The systemic nature of CKD

Carmine Zoccali et al.

NATURE REVIEWS NEPHROLOGY (2017)

Article Cell Biology

Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1

Haiting Huang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Urology & Nephrology

Recent trends in the prevalence of chronic kidney disease: not the same old song

Raymond K. Hsu et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)

Article Environmental Sciences

Tnf-α inhibition by infliximab as a new target for the prevention of glycerol-contrast-induced nephropathy

Murat Saritemur et al.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2015)

Review Urology & Nephrology

Renal interstitial fibrosis: mechanisms and evaluation

Alton B. Farris et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)

Article Multidisciplinary Sciences

Mixed Organic Solvents Induce Renal Injury in Rats

Weisong Qin et al.

PLOS ONE (2012)

Article Urology & Nephrology

Protective Effect of Infliximab on Ischemia/Reperfusion-Induced Damage in Rat Kidney

Cemal Tasdemir et al.

RENAL FAILURE (2012)

Article Rheumatology

Disease activity and cognition in rheumatoid arthritis: an open label pilot study

Graham Raftery et al.

ARTHRITIS RESEARCH & THERAPY (2012)

Review Veterinary Sciences

Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories

Jose A. Ramos-Vara et al.

JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2008)

Article Urology & Nephrology

The epidemiology of severe acute kidney injury: From BEST to PICARD, in acute kidney injury: New concepts

Roberto Pisoni et al.

NEPHRON CLINICAL PRACTICE (2008)

Article Gastroenterology & Hepatology

Favorable response to subcutaneous administration of infliximab in rats with experimental colitis

John K. Triantafillidis et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)

Review Endocrinology & Metabolism

Cytokine dysregulation, inflammation and well-being

IJ Elenkov et al.

NEUROIMMUNOMODULATION (2005)

Article Pathology

Method for the measurement of antioxidant activity in human fluids

D Koracevic et al.

JOURNAL OF CLINICAL PATHOLOGY (2001)